Target Name: LOC101927066
NCBI ID: G101927066
Review Report on LOC101927066 Target / Biomarker Content of Review Report on LOC101927066 Target / Biomarker
LOC101927066
Other Name(s): Uncharacterized LOC101927066 | uncharacterized LOC101927066

LOC101927066: A Potential Drug Target and Biomarker

LOC101927066 is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and kidneys. Its unique expression pattern and subcellular localization have led to its potential as a drug target or biomarker.

The protein LOC101927066 is characterized by itsserine-threonine-aspartic acid (STAA) sequence, which is a common feature of proteins that are involved in various cellular processes, including signaling, protein-protein interactions, and intracellular signaling. The STAA sequence is also known as the \"intramolecular signaling gene\" (IMSG) gene.

LOC101927066 has been shown to play a role in intracellular signaling, specifically in the regulation of the blood-brain barrier (BBB) and in the development of various diseases, such as cancer. The BBB is a specialized barrier that separates the brain from the blood and is designed to prevent the entry of harmful substances into the brain. However, in some diseases, the BBB may become compromised, leading to the entry of harmful substances and the development of symptoms.

Studies have shown that LOC101927066 is involved in the regulation of the BBB and that its expression levels are regulated by various factors, including cell type, signaling pathways, and environmental factors. For example, high levels of LOC101927066 have been shown to be associated with the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and with the progression of certain cancers.

In addition to its potential role in disease, LOC101927066 has also been shown to be a potential biomarker for several diseases. For example, LOC101927066 has been used as a biomarker for various types of cancer, including breast, lung, and ovarian cancer. The protein has also been shown to be involved in the regulation of cell cycle progression and has been linked to the development of certain diseases, such as neurofibromatosis.

The potential drug target for LOC101927066 is the use of small molecules or biochemicals that can modulate its expression and activity. This is an attractive approach for the development of new treatments for a variety of diseases.

LOC101927066 has been shown to play a role in the regulation of the blood-brain barrier and has been linked to the development of various diseases. Its unique expression pattern and subcellular localization make it a promising candidate as a drug target or biomarker. Further research is needed to fully understand its role in various biological processes and to develop new treatments based on its unique properties.

Protein Name: Uncharacterized LOC101927066

The "LOC101927066 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC101927066 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC101927082 | LOC101927108 | LOC101927143 | LOC101927164 | LOC101927166 | LOC101927169 | LOC101927179 | LOC101927188 | LOC101927199 | LOC101927216 | LOC101927243 | LOC101927245 | LOC101927253 | LOC101927263 | LOC101927269 | LOC101927314 | LOC101927369 | LOC101927394 | LOC101927421 | LOC101927476 | LOC101927483 | LOC101927495 | LOC101927518 | LOC101927531 | LOC101927548 | LOC101927550 | LOC101927571 | LOC101927588 | LOC101927598 | LOC101927605 | LOC101927609 | LOC101927627 | LOC101927636 | LOC101927668 | LOC101927712 | LOC101927727 | LOC101927741 | LOC101927745 | LOC101927770 | LOC101927787 | LOC101927825 | LOC101927827 | LOC101927834 | LOC101927840 | LOC101927853 | LOC101927855 | LOC101927857 | LOC101927863 | LOC101927896 | LOC101927897 | LOC101927910 | LOC101927932 | LOC101927942 | LOC101927947 | LOC101927960 | LOC101927967 | LOC101927971 | LOC101927995 | LOC101927998 | LOC101928004 | LOC101928007 | LOC101928008 | LOC101928012 | LOC101928014 | LOC101928047 | LOC101928053 | LOC101928080 | LOC101928093 | LOC101928120 | LOC101928135 | LOC101928143 | LOC101928152 | LOC101928163 | LOC101928180 | LOC101928195 | LOC101928201 | LOC101928219 | LOC101928230 | LOC101928251 | LOC101928268 | LOC101928269 | LOC101928272 | LOC101928273 | LOC101928274 | LOC101928281 | LOC101928331 | LOC101928334 | LOC101928338 | LOC101928344 | LOC101928347 | LOC101928351 | LOC101928354 | LOC101928371 | LOC101928372 | LOC101928373 | LOC101928381 | LOC101928385 | LOC101928387 | LOC101928391 | LOC101928416